Efficacy of Osimertinib in Patients With Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations
Latest Information Update: 21 Dec 2023
At a glance
- Drugs Osimertinib (Primary)
- Indications Carcinoma; Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 21 Dec 2023 New trial record